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The term syndrome X has been applied to the association of hypertension, non-
insulin-dependent diabetes mellitus (NIDDM), android obesity, insulin resistance,
and dyslipidemia. In this paper, based on population samples from Tecumseh,
Michigan, and Hiroshima, Japan, characterized by persons ≥40 years of age, we
examine the validity of regarding this constellation of traits as a true syndrome,
i.e., an array of traits with a single, unifying pathophysiology underlying its com-
ponents. Data were not available on insulin resistance and dyslipidemia, and
obesity was expressed as body mass index (BMI) without the division into an-
droid and non-android types. The four ethnic-gender data sets were analyzed
on the basis of two age classes, age ≥40 years and age ≥50 years, and two
obesity classes, BMI ≥27 and ≥30. A simple χ2 test of goodness-of-fit under a
model of independence revealed non-random associations between hypertension,
NIDDM, and BMI which were in part attributable to an excess of persons with
all three traits. However, when the four data sets were subjected to separate log-
linear analyses of the three-way association tables, none of the three-factor inter-
action terms (i.e., syndrome X) was significant. High significance was, however,
observed in the two-factor interaction term for BMI*hypertension. It is con-
cluded that the significant association between these three traits is driven by
the BMI*hypertension interaction, and there is no evidence in these data sets
of a significant role for a syndrome X. Genet. Epidemiol. 15:19–32, 1998.
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INTRODUCTION
Recent years have witnessed increasing interest in an entity most commonly
referred to as syndrome X, the association of non-insulin-dependent diabetes melli-
tus (NIDDM), essential hypertension, truncal-abdominal (android) obesity, insulin
resistance, and dyslipidemia [cf. Björntorp, 1992; Gillum, 1987; Kaplan, 1989;
Landsberg, 1986; McKeigue et al., 1991; Modan et al., 1985; Reaven, 1988; Sims
and Berchtold, 1982]. Essentially the same complex has also been termed the insulin
resistance syndrome (IRS) [Defronzo and Ferrannini, 1991; Edwards et al., 1994].
Carmelli et al. [1994], employing the twin panel approach, have suggested that
this is a genetic syndrome, individuals with the constellation sharing a common
latent factor of which 59% was attributed to genetic and 41% to environmental
effects. There is no doubt that individuals are encountered exhibiting this asso-
ciation and that in some data sets they occur in numbers exceeding random ex-
pectation [Criqui et al., 1986; Ferrannini et al., 1991]. The term “syndrome,”
however, is in its strict (and most useful) sense applied to a non-random associa-
tion of traits stemming from a single basic aberration. Given the relatively high
prevalence of obesity, essential hypertension, and NIDDM in most affluent na-
tions, instances of this association can be expected on the basis of chance alone.
While one can elect to term such a chance association a syndrome, when so used
the term does not carry the usual implication of a unifying pathophysiology un-
derlying its components.
What is needed to determine whether the associations of these three entities
exceed random expectation are survey data on a total population (or randomly se-
lected subset thereof) whose members were not selected for study with reference to
any of the traits in question. We have found no analysis of such a data set in the
literature. Fortunately, we have access to two sets of observations that seem to meet
most of these criteria, one involving a defined population of Japanese living in
Hiroshima, Japan, and the other involving a defined population of Caucasians living
in Tecumseh, Michigan.
Japanese Population
One of the major programs among the studies of the Radiation Effects Research
Foundation (RERF) on the potential delayed effects of exposure to the atomic bombs
is the so-called Adult Health Study (AHS). The AHS cohort at its inception com-
prised 19,961 subjects, about half of whom were within 2,000 m of the hypocenter, a
quarter beyond 3,000 m, and the remainder not in the city (NIC) at the time of bomb-
ing. Since 1958, all subjects have been invited to participate in biennial health ex-
aminations. (For a full description of the study see Hollingsworth and Beebe [1960].)
The follow-up for the 5,000 NIC subjects was discontinued after 1974. Because of
high attrition and the fear that the sample would eventually become too small for the
detection of radiation effects, 2,436 subjects were added to the study group in 1977.
These health examinations consist of history taking, general physical examination,
and laboratory tests that include blood pressure, blood sugar, and various anthropo-
metric measurements such as height and weight. The results presented here are drawn
from the data collected between January 1991 and December 1992, in Hiroshima
only. This represents the 16th–17th biennial examination cycle.
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Tecumseh Population
The Tecumseh Community Health Study began in 1959 as a prospective epide-
miological investigation of health and disease in a geographically defined area con-
sisting of the town of Tecumseh, MI, and the surrounding rural area [Napier, 1962;
Napier et al., 1970]. During the periods 1959–1960 and 1962–1965, some 80% of
the total population, including both sexes and all ages, were studied in comprehen-
sive health examinations. Participants gave detailed medical histories to lay examin-
ers, and positive responses were further investigated during physician interviews.
Included in the survey measurements were standardized assessments of height, weight,
and blood pressure [Johnson et al., 1965]. In addition, blood was obtained from all
willing participants for determination of blood glucose. Most blood specimens were
obtained 1 hr after administration of 100 g of glucose solution orally, without regard
for the proximity to a previous meal or to time of day [Johnson et al., 1965]. There
were no African-Americans in the sample.
Shortcomings of the Data Set
There are several important shortcomings to these data sets. First, in the studies
involved, no clear distinction was drawn between android and non-android obesity.
We are forced to treat all obesity as a single entity, quantitated as body mass index
(BMI), defined as (weight in kilograms)/(height in meters2).
Second, BMI, blood pressure level, and the impairment of glucose metabolism
termed NIDDM are basically continuous variables, and a truly sophisticated analysis
would treat them as such. Unfortunately for our present purposes, in countries with a
high level of medical practice, such as the United States and Japan, although some
fraction of undiagnosed hypertension and NIDDM is encountered in population sur-
veys, physician intervention into the disease process following diagnosis has materi-
ally altered the expression of the disease. We are, therefore, forced to define essential
hypertension either as an observed seated diastolic blood pressure ≥90 mm Hg or a
history of a previous diagnosis and current antihypertensive treatment. With respect
to the diagnosis of NIDDM in Tecumseh, participants were classified as diabetic
even if no blood glucose determination was performed, if they reported having been
diagnosed as diabetic by a physician, and had ever taken insulin or an oral hypogly-
cemic agent. Participants who did not meet these criteria for diabetes but had a 1 hr
post-challenge blood glucose concentration greater than 224 mg/dl or a casual level
greater than 124 mg/dl were classified as hyperglycemic. The criteria for the diag-
nostic post-challenge glucose value were based on results obtained in earlier glucose
tolerance testing performed in the Tecumseh population [Hayner et al., 1965; Ostrander
et al., 1980], and the criteria for the casual value on U.S. Public Health Service
criteria [O’Sullivan and Mahan, 1965]. For the purpose of the present analysis, dia-
betes and hyperglycemia were combined, and persons not classified as diabetic or
hyperglycemic were considered non-diabetic. The classifications forming the basis
for earlier reports [Butler et al., 1982] are maintained in the present analysis. In the
RERF data, the situation is slightly different. NIDDM has been a subject of long-
standing interest to the staff, beginning with the first round of examinations in the
AHS [Freedman et al., 1965]. At each round of the examinations, which now amount
to 16–17 for the subjects of the present study, at a minimum a blood sugar has usu-
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ally been obtained (fasting or post-prandial, as the case may be). For participants
who were classified as hyperglycemic, more complete studies have been performed
based on the criteria defined by the Japan Diabetes Association [Kuzuya, 1970].
On the other hand, physician intervention into the therapy for obesity is so un-
successful that the BMI as determined at the time of examination is that employed in
the analysis, with no reference to previous attempts at therapy. However, as with the
arbitrary definitions of hypertension and NIDDM, the use of a specific BMI to de-
fine obesity also presents a problem. There is room for a difference of opinion as to
when an individual is “plump” or “stout” and when obese. We will analyze the data
with regard to two different definitions of obesity, namely, BMI ≥27, and BMI ≥30.
The resulting two data sets are not independent of one another. There is a further
issue with respect to BMI in that the data are cross sectional rather than longitudinal.
For one reason or the other, people sometimes lose weight after the diagnosis of
NIDDM. Thus, for our purposes, the best measurement would be maximum BMI,
but this is simply not available.
Third, we mention that insulin resistance and dyslipidemia are often regarded as a
component of syndrome X. We do not have data on all our subjects on these characteris-
tics, and so these attributes do not enter into our statistical treatment. However, it will be
shown that such data are not essential to the argument we are developing.
A further complication of the data is that all three of the entities under consideration
are age-related. For purposes of analysis, and to permit comparison with similar data
sets, it is necessary to introduce arbitrary age standards into the data if the prevalence of
trait or syndrome frequency is to be defined. We will present the data in terms of all
members of the two populations ≥40 years of age and all members ≥50 years of age.
Because of the special circumstance in the construction of the Japanese cohort (i.e., alive
at the time of the atomic bombings), the youngest member was actually ≥45 years of age.
The four resulting data sets are again not independent of one another.
STATISTICAL METHODS
To investigate the null hypothesis that the observed frequency distribution was
explained by the independent contribution of each of the three disease traits (obesity
status, hypertension status, and diabetes status), a χ2 goodness-of-fit test was applied
to the data in the following manner. First, marginal relative frequencies of each dis-
ease category were calculated. Then, the expected cell frequencies were estimated
by multiplying the appropriate marginal relative frequencies together for each cell of
the 2 × 2 × 2 table and multiplying this probability by the total sample size of that
particular gender by ethnic-specific subgroup. The χ2 goodness-of-fit between ob-
served and expected frequencies under the model of independence had 4 degrees of
freedom (8 cells – 1–3 parameters needed for estimation of expectation = 4 degrees
of freedom).
To test whether the marginal frequency of each of these disease traits was inde-
pendent of gender within each ethnicity or was independent of ethnicity within each
gender, we used the 2 × 2 χ2 test of association. We did not pool genders when
testing for ethnic differences nor did we pool ethnic subgroups when testing for
gender differences. We also performed a Mantel-Haenszel test on these data, with
essentially the same results and inferences, but prefer to present the analysis in its
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present form as providing a more descriptive picture of the combined differences in
the frequencies of these diseases among the gender and ethnic groups.
To investigate the null hypothesis that the observed distribution of the data was
not associated with an interaction between BMI, hypertension, and diabetes (i.e.,
syndrome X) log-linear models were employed. For the three-way tables (i.e., 2 × 2
× 2) represented in Table I, the complete or saturated log-linear model is:
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where αi, βj, and γk represent the deviations of the marginal frequencies from 0.5 for
BMI, hypertension, and diabetes, respectively, αβij , αγik, and βγjk represent two-fac-
tor interactions, and αβγijk is the three-factor interaction term; µ represents the over-
all grand mean of the log fij . The null hypothesis that αβγijk = 0 was tested by
comparing the maximum likelihood of the saturated model with the maximum likeli-
hood of the reduced model with only two-factor interactions using the standard like-
lihood ratio test. Likewise, the null hypothesis that αβij = 0 was tested by comparing
the maximum likelihood of a model with all three two-factor interaction terms with
the maximum likelihood of a reduced model with only the αγik and the βγjk interac-
tion terms. The other two-factor terms were tested in an analogous fashion.
DATA
The basic data are presented in Tables I and IV, following the conventions out-
lined earlier. We emphasize again that the four sets of ethnic-gender tabulations are
independent of one another, but the four sets of age-BMI tabulations nested within
the preceding sets are not independent. Table I presents the data on age ≥40 years,
BMI ≥27, and the results of the χ2 goodness-of-fit test, for males and females sepa-
rately for both cities. Table II presents the results of applying the log-linear model to
these data, while Table III provides numerical examples of the predictions resulting
from omitting the three-factor interaction term (αβγijk) or all the interaction terms
except BMI*hypertension (αβij). Table IV presents the other three data sets, but no
analysis. However, these data have been analyzed in a fashion similar to the first set,
and reference will be made to the results of the analysis in what follows.
RESULTS
Eight diagnostic categories were possible based on whether or not an individual
had obesity, hypertension, NIDDM, or some combination thereof. For the first set of
analyses, the definition of obesity is a BMI ≥27. In Table I, the observed frequency
of individuals ≥40 years of age that fall into one of the eight possible diagnostic
categories is presented for each gender- and ethnic-specific subgroup. The marginal
frequencies of each of the separate diagnostic categories are also presented. We note
that these marginal frequencies were significantly gender dependent in the Japanese
sample, and ethnic group dependent in both males and females. For example, the
marginal frequency of high BMI was significantly greater in Tecumseh males than in
Japanese males (marginal frequency of 0.379 compared to 0.067) and significantly
TABLE I. Observed and Expected (Under a Mode of Independence) Frequencies of the Eight BMI, Hypertension (HYT), and NIDDM Diagnostic Categories,
as Well as the Marginal Frequencies, for Males and Females at Least 40 Years of Age in the Tecumseh and Japanese Samples
Tecumseh Japan
Diagnoses Males Females Males Females
BMI ≥27 HYT NIDDM Observed Expecteda χ2 Observed Expecteda χ2 Observed Expecteda χ2 Observed Expecteda χ2
N N N 391 344 6.48 385 316 14.98 656 647 0.12 1,508 1,422 5.20
Y N N 168 210 8.34 159 224 18.73 38 47 1.66 144 204 17.78
N Y N 184 228 8.53 176 233 14.00 326 333 0.14 481 553 9.23
N N Y 48 51 0.19 55 54 0.02 101 102 0.00 117 142 4.51
Y Y N 178 139 10.79 218 165 17.05 31 24 1.99 125 79 26.26
Y N Y 29 31 0.16 33 38 0.70 8 7 0.06 20 21 0.01
N Y Y 34 34 0.00 27 40 4.10 51 52 0.03 66 55 2.07
Y Y Y 26 21 1.35 45 28 10.10 5 4 0.39 23 8 28.55
Total 1,058 1,098 1,216 2,484
χ2 test of independence (df = 4) 35.849 79.680 4.398 93.612
P <0.0001 <0.0001 0.355 <0.0001
Marginal frequencies
High BMI 0.379** 0.414** 0.067*,** 0.126*,**
Hypertension 0.399** 0.424** 0.340*, * 0.280*,**
NIDDM 0.129** 0.146** 0.136*,** 0.091*,**
aExpected under a model of independence.
*Marginal frequency is gender dependent within ethnic group (P < 0.05).
**Marginal frequency is ethnic-group dependent within gender (P < 0.05).
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TABLE II. Results of Likelihood Ratio Tests Comparing the Likelihood of Log-Linear Models With and Without the Three- and Two-Factor Interaction
Terms Between BMI, Hypertension (HYT), and NIDDM (DIAB)†
Model 1 vs. model 2 Model 2 vs. model 3 Model 2 vs. model 4 Model 2 vs. model 5
(Ho: DIAB*HYT*BMI = 0) (H o: DIAB*HYT = 0) (H o: BMI*HYT = 0) (Ho: BMI*DIAB = 0)
χ2 P χ2 P χ2 P χ2 P
Tecumseh
Males 2.32 0.1281 0.82 0.3652 32.17 <0.0001 0.16 0.6892
Females 0.05 0.8297 0.03 0.8625 74.91 <0.0001 3.61 0.0574
Japan
Males 0.19 0.6604 0.00 0.9999 3.74 0.0531 0.38 0.5376
Females 0.62 0.4327 11.81 0.0006 58.28 <0.0001 5.18 0.0228
†Model 1: Ln(f) = DIAB + HYT + BMI + DIAB*HYT + DIAB*BMI + HYT*BMI + DIAB*HYT*BMI; model 2: Ln(f) = DIAB + HYT + BMI + DIAB*HYT +
DIAB*BMI + HYT*BMI; model 3: Ln(f) = DIAB + HYT + BMI + DIAB*BMI + HYT*BMI; model 4: Ln(f) = DIAB + HYT + BMDIAB*HYT + DIAB*BMI ;
model 5: Ln(f) = DIAB + HYT + BMI + DIAB*HYT + HYT*BMI.
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TABLE III. Expected Frequencies of the Eight BMI, Hypertension (HYT), and NIDDM Diagnostic Categories Under a Model Containing All Two-Factor
Interaction Terms and Under a Model With Only the BMI*HYT Interaction Term, for Males and Females at Least 40 Years of Age in the Tecumseh and
Japanese Samples
Tecumseh Japan
Diagnoses Males Females Males Females
BMI ≥27 HYT NIDDM Observed Expecteda Expectedb Observed Expecteda Expectedb Observed Expecteda Expectedb Observed Expecteda Expectedb
N N N 391 387 382 385 384 376 656 655 654 1,508 1,506 1,477
Y N N 168 172 171 159 160 164 38 39 40 144 146 149
N Y N 184 188 190 176 177 173 326 327 326 481 483 497
N N Y 48 52 57 55 56 64 101 102 103 117 119 148
Y Y N 178 174 178 218 217 225 31 30 31 125 123 135
Y N Y 29 25 26 33 32 28 8 7 6 20 18 15
N Y Y 34 30 28 27 26 30 51 50 51 66 64 50
Y Y Y 26 30 26 45 46 38 5 6 5 23 25 13
Total 1,058 1,098 1,216 2,484
aExpectation under the model with all two-factor interaction terms.
bExpectation under the model with only BMI*HYT interaction terms.
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TABLE IV. Observed Frequencies of the Eight BMI, Hypertension (HYT), and NIDDM Diagnostic Categories Under Three Different Parti ionings of the
Data, Namely, BMI ³27 kg/m2 and Age ³50 years; BMI ³30 kg/m2 and Age ³40 years; and BMI ³30 kg/m2 and Age ³50 years
Tecumseh Japan
Males Females Males Females
BMI BMI BMI BMI BMI BMI BMI BMI BMI BMI BMI BMI
Diagnoses ≥27 and ≥ 30 and ≥ 30 and ≥27 and ≥30 and ≥30 and ≥27 and ≥30 and ≥30 and ≥27 and ≥30 and ≥30 and
High age ≥50 age ≥40 age ≥50 age ≥50 age ≥40 age ≥50 age ≥50 age ≥40 age ≥50 age ≥50 age ≥40 age ≥50
BMI HYT NIDDM years years years years years years years years years years years years
N N N 213 501 273 190 470 238 495 688 513 1,317 1,610 1,408
Y N N 95 58 35 89 74 41 22 6 4 128 42 37
N Y N 102 291 154 115 256 165 287 351 308 459 564 535
N N Y 37 66 51 35 65 44 87 108 94 108 132 121
Y Y N 80 71 28 145 138 95 26 6 5 110 42 34
Y N Y 24 11 10 26 23 17 8 1 1 17 5 4
N Y Y 21 46 31 21 34 27 43 56 47 65 73 72
Y Y Y 17 14 7 35 38 29 4 0 0 20 16 13
Total 589 1,058 589 656 1,098 656 972 1,216 972 2,224 2,484 2,224
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greater in Tecumseh females than in Japanese females (marginal frequency of 0.414
compared to 0.126). In contrast, Tecumseh males and females had approximately the
same marginal frequencies for each of the three diseases while Japanese males had
significantly higher marginal frequencies of hypertension and NIDDM, and a sig-
nificantly lower frequency of high BMI, than Japanese females.
Comparing the observed frequency distribution with the expected frequencies
under a model of independence among each of the characteristics (Table I), it is
evident that there are significant departures from random association (P < 0.001) in
Tecumseh males, Tecumseh females, and Japanese females, but not Japanese males.
As indicated by the χ2 values associated with each particular combination, where the
departure from random association is significant in the total sample, it is in part
attributable to a substantial excess of individuals with the triad of diseases but other
entries make significant contributions, and especially the association of obesity and
hypertension. We thus confirm previous reports of an excess of individuals with the
triad in some “populations” [Criqui et al., 1986; Ferrannini et al., 1991].
To investigate more thoroughly the nature of the association between high BMI,
hypertension, and NIDDM, we used log-linear models [Bishop et al., 1975; Sokal
and Rohlf, 1995]. The results from the likelihood ratio test of the complete model (model
1) including a three-factor interaction term vs. the reduced model (model 2) containing
no three-factor interaction term are presented in Table II for each gender- and ethnic-
specific subgroup. In every subgroup, the inference was the same, namely, that there was
no statistically significant evidence for a separate three-factor association. This result is
unlikely to be due to a type II error, because of the large sample sizes associated with
each subgroup and because the magnitude of the P values associated with this test is not
even close to marginal significance in three of the four subgroups.
Subsequent analyses of each two-factor interaction term are also presented in
Table II and indicate that there is a significant association between the BMI and
hypertension in all four subgroups: Tecumseh males, Tecumseh females, Japanese
males, and Japanese females. These analyses also indicated a significant association
between BMI and NIDDM in females, but not males. Finally, a significant associa-
tion between hypertension and NIDDM was observed in Japanese females only. Table
III illustrates the actual numerical expectations with two of the “reduced” models for
which the results of significance tests were given. Note, on the one hand, the very
minor effect of omitting the three-factor interaction term, and, on the other hand,
how well the data are fit by a model in which the only interaction term is
BMI*hypertension. For example, we point out that the model with all two-factor
interaction terms predicts a larger number of individuals expected to have the pur-
ported syndrome X than we actually observed in any of our samples. Thus, there are
simply no individuals where a “syndrome X” must be invoked to explain the data.
This conclusion is further supported by examining the expected number of individu-
als with the purported “syndrome X” using the model with only the BMI*hypertension
interaction term. This model explains 100% of the observed number of individuals
with all three diseases in both Tecumseh males and Japanese males. We do not be-
lieve that these inferences would be influenced by additional information on insulin
resistance or dyslipidemia in these subjects.
As mentioned previously, we also investigated the associations between high
BMI, hypertension, and NIDDM using an alternative definition of obesity of BMI
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≥30 and a second age cutoff of ≥50 years of age. In Table IV, we present the ob-
served frequency distributions of the eight diagnostic categories when these different
criteria for inclusion in the samples and for inclusion in the obesity category are
followed. The same log-linear analyses as presented above were conducted on each
of these different data sets, and, in each, there was still no statistically significant
evidence for a three-factor interaction which would indicate a non-random associa-
tion between all three diseases. In general, the original inferences from the first analy-
sis hold with only a few, sporadic exceptions. For example, in Japanese males, the
interaction between high BMI and hypertension becomes non-significant when the
cutoff for inclusion in the high BMI category shifts from ≥27 to ≥30, regardless of
the age cutoff. In Tecumseh males, the interaction between high BMI and hypertension
becomes non-significant only in the ≥30 BMI and ≥50 years of age cutoff of the data. We
also note that in females, when the inclusion criterion for the high BMI category be-
comes more stringent (i.e., is BMI ≥30), the strength of the association between high
BMI and NIDDM becomes more significant (P < 0.02) (analyses not shown).
DISCUSSION
We comment first on the relatively high frequency in these two populations of
the three components of syndrome X. Granted the arbitrary definition of these three
traits, by these or any other reasonable definitions, the frequencies of these traits and
the size of the two study populations would seem to be adequate for the detection of
a syndrome X if such occurs in significant numbers. At the same time, we note an
interesting difference between the two populations. Although there are significant
gender-ethnic differences with respect to all three traits, this is much more marked
with reference to BMI than for NIDDM or hypertension (see Table I). Otherwise
stated, the Japanese exhibit roughly comparable levels of NIDDM and hypertension
even though the fraction with an elevated BMI as defined is only about one quarter
that observed in the Tecumseh population. In any rigorous effort to define ethnic
differences in susceptibility to NIDDM and hypertension, it would be desirable to
compare populations in which the BMIs were more similar. The validity of this com-
parison is also marred by the previously mentioned fact that because of the age com-
position of the cohort, the age cutoff for the Japanese data is ≥45 years, whereas for
the Tecumseh cohort it is ≥40 years.
The analysis does not exclude the possibility that buried in the association of
NIDDM/hypertension/BMI ≥27, there are a few cases of a “true” syndrome X, i.e.,
an association not explicable by the overlapping occurrence of three common diag-
nostic entities, but due to a specific gene or genes. Thus, the situation could be analo-
gous to the recognition that among the many cases of NIDDM (the predisposition to
which is usually treated as a oligogenic disorder), there is an uncommon dominantly
inherited entity now termed maturity-onset type diabetes of youth (MODY), in which
the impairment of sugar metabolism has an early onset, progresses slowly, and ap-
pears to be inherited as a simple dominant trait [Tattersall, 1974]. In the 20 years
since its recognition, MODY has now been subdivided into three rare subtypes [re-
viewed in Spielman and Nussbaum, 1992; Fajans et al., 1994]. However, as demon-
strated earlier, there is at present little need to invoke a true genetic syndrome to
explain the observed association.
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Carmelli et al. [1994], analyzing data on “syndrome X” similar to that in this
paper and derived from the panel of male twin veterans of World War II established
under the auspices of the National Research Council, as described by Jablon et al.
[1967] and Hrubec and Neel [1978], stated: “Multivariate genetic modeling of the
correlation in liabilities to develop these conditions suggested the presence of a com-
mon latent factor mediating the clustering of hypertension, diabetes and obesity in
this twin sample. This common factor was influenced by both genetic and environ-
mental effects (59% genetic, 41% environmental).” The analysis was based on a
total of 2,508 Caucasoid twin pairs of known zygosity, of whom 1,236 pairs (2,473
persons) were dizygous, and the remainder monozygous. We note that in their data,
for both the monozygous and dizygous twins, there was no excess over random ex-
pectation of individuals concordant for hypertension, diabetes, and obesity. Thus,
from the population standpoint, these data provide no evidence for a syndrome X.
Hong et al. [1997], in a study in Swedish twins with IRS (the definition including
hypertension), endorse the concept that “all of the five principal metabolic compo-
nents contained in IRS are more or less influenced by a single latent genetic factor,”
but then note, “systolic blood pressure was related to IRS, albeit weakly, only through
genetic effects.” Their data are not presented in a fashion such that the question of an
excess in that population of IRS (including hypertension) over random expectation
can be tested.
On the other hand, Mitchell et al. [1996], in a family-based study of the IRS which
included hypertension as a component, find that “the genetic correlations of insulin lev-
els with systolic and diastolic blood pressures were low.” These observations of Mitchell
et al. [1996], plus Hong et al. [1997], together with the data of this paper, suggest that the
terms IRS and syndrome X should not be used interchangeably. Hypertension is not an
integral aspect of the IRS, although it is often encountered in persons with the IRS.
Should, further, our findings be confirmed in other but more complete studies of total
populations, then the justification for recognizing a syndrome X disappears, and it would
seem appropriate to discontinue the use of the term.
In these two data sets, the greater strength of the association between BMI ≥27
and hypertension than between BMI ≥27 and NIDDM is noteworthy. This is not the
stereotypical view, but further discussion would be premature until data are available
permitting the subdivision of persons with BMI ≥27 or ≥30, and the analyses, into
android and non-android types of obesity [for population data see Cassano et al.,
1992; Haffner et al., 1987; Hartz et al., 1984; Iso et al., 1991; Ohlson et al., 1985;
Williams et al., 1987]. However, we question whether an analysis based on breaking
the subset with android obesity out of the more general category of obesity could
reverse the relative strengths of these two associations or, for that matter, together
with data on dyslipidemia and insulin resistance, reveal a sufficient association of
hypertension, NIDDM, and android obesity to establish the concept of syndrome X
as a major, uniquely determined genetic entity.
Thus, our findings lead us to consider that “syndrome X” is very predominantly
the result of an overlap among the distributions of multifactorial etiologies underly-
ing each of three common diseases. The genetic analyses of these multifactorial dis-
eases present the most difficult research challenge facing human geneticists today.
For the purposes of understanding both etiology and prediction, it is particularly
relevant to recognize that variation in many disease susceptibilities among individu-
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als in the population at large is a consequence of the intersection of exposures and
genetically permissive factors. As we gain more information about the molecular
biology of the metabolic systems involved in the common diseases and identify more
causal factors, we are faced with the realization that fewer and fewer cases of the
common diseases will be associated with a specific etiology, i.e., an interaction be-
tween a particular genotype and a particular set of environmental exposures [Sing et
al., 1996]. This is particularly true in the case of an individual with multiple com-
mon diseases such as syndrome X. Few studies of common multifactorial diseases
recognize this reality.
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